NCT05445323: Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 8 taking part
- Started
- 24 Aug 2022
- Primary completion
- Sep 2029
- Arms
- Cohort 1/ Cohort 2/ Cohort 3
- Results
- None posted
- 6 Jul 2022: Trial registered
- 24 Aug 2022: Trial started